Oncotarget published "Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma"…

Home »
Oncotarget published "Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma"…
The first artificial intelligence (AI) endoscopy module developed specifically to help detect adenomas during routine colonoscopy is making its debut…
A big change in drug treatment for cancer is arriving in Georgia. It’s not a new medication. What’s coming is something…
Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death…
A large, retrospective study shows how germline genetic testing has evolved over time in women with breast or ovarian cancer…
NEW YORK (Reuters Health) – Previously untreated patients with advanced renal-cell carcinoma live twice as long without disease progression when…
Vir Biotechnology and Britain’s GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with cancer are considered at…
The checkpoint inhibitor nivolumab is efficacious and well tolerated when used as adjuvant therapy in patients who have undergone radical…
Although rates of smoking have been declining in the United States, smoking is still contributing substantially to the cancer burden,…